| Application no. and date | 09752988.7 (espacenet) (Federated) (European Patent Register), 20091113 | | Patent/reg. no. and date | DK/EP 2358676, 20121010 | | Publication date | 20110824 | | Priority no. and date | US 114541 P, 20081114 | | EP pub. no. and date |
EP 2358676 20110824 | | Effective date | | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | 145479 | | Inventor | RAPTA, Miroslav, 411 E. Duane Avenue
Sunnyvale
California 94085, US,
PATTERSON, Lori Jean, 3 Whitney Street
San Francisco
California 94131, US,
CHAO, Robert, 1121 Doyle Circle
Santa Clara
California 95054, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4409 (2006.01) , A61P 25/00 (2006.01) , C07D 211/22 (2006.01) | | Title | Krystallinsk form af en 4-[2-(2-fluorphenoxymethyl)phenyl]-piperidinforbindelse | | Int. application no. | US2009064306 | | Int. publication no. | WO2010056939 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
